Analysts, rejoice. Metys® offers predefined dashboards for quick answers and a powerful report builder for custom views – plus Excel integration for seamless workflows. It’s market intelligence, your way. Explore Mety...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Coronavirus vaccine: how pharma is picking up the pace
A PharmaPhorum article featuring commentary from ICON's Dr. Nuala Murphy and Dr. James Cummings.
-
COVID-19 will spur decentralised and hybrid trials – Novartis hails digital investment
An article featuring commentary from Dr. Nuala Murphy regarding the use of decentralised and hybrid trials during the COVID-19 crisis.
-
Transforming cell and gene therapy trial design and execution
With over 400 dedicated Cell and Gene Therapy professionals globally, ICON has developed tools and best practices to transform CGT trial design and execution.
-
COVID-19 vaccine response
James Cummings, President, ICON Government & Public Health Solutions, and Beth Tulip, Vice President, Project Management, Vaccines & Infectious Diseases, discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccine.
-
Translation services and the race for a coronavirus vaccine
An article featuring commentary from Adelina Lear regarding the role of language services in the drug development lifecycle.
-
ICON launches Coronavirus Observatory
This article discusses ICON’s Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues.
Read more about ICON's expertise in COVID-19 clinical trials.
-
Role of data in revolutionising the CRO industry
In a wide-ranging interview with PharmaBoardroom, ICON CIO, Tom O’Leary highlights the role of data in revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
-
Data management landscape is still changing, are we adapting fast enough?
A thought leadership article authored by Rona O’Donnell centred around the changing nature of clinical data management.
-
The Significant Role of a Robust Regulatory Intelligence Process in Global Safety Submissions
Pharmacovigilance insights on the efforts towards the international standardisation of electronic transmission of drug safety information to achieve a unified objective of patient safety, written by Arinder Sihota and Trupti Gurjar, which featured in the March 2020 edition of Pharma Focus.
-
The Promise of IoMT
A thought leadership article authored by David Novotny and Marie McCarthy, which focuses on the advances in connected devices such as wearable biosensors and mobile trackers.
